Neurocrine Biosciences Inc (NASDAQ:NBIX)

85.25
Delayed Data
As of Feb 16
 -0.32 / -0.37%
Today’s Change
39.21
Today|||52-Week Range
91.82
+9.87%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Gorman Kevin Charles
Chief Executive Officer
Sale2/06/2018100,000$80.07$8.0M+3.36%
Obrien Christopher Flint
Chief Medical Officer
Sale5/18/2017105,634$53.32$5.6M+59.11%
Grigoriadis Dimitri E
Chief Research Officer
Sale2/09/201871,775$77.98$5.6M+7.53%
Obrien Christopher Flint
Chief Medical Officer
Sale11/02/201745,299$69.71$3.2M+17.13%
Obrien Christopher Flint
Chief Medical Officer
Sale9/05/201752,817$57.50$3.0M+46.91%
Grigoriadis Dimitri E
Chief Research Officer
Sale11/08/201730,000$74.58$2.2M+15.12%
Lloyd Smith Malcolm
Chief Regulatory Officer
Sale1/02/201818,084$77.52$1.4M+7.50%
Gano Kyle
Chief Business Development Officer
Sale9/06/201720,393$60.00$1.2M+45.38%
Grigoriadis Dimitri E
Chief Research Officer
Sale2/12/201814,593$80.00$1.2M+3.75%
Gorman Kevin Charles
Chief Executive Officer
Sale5/02/201721,739$53.23$1.2M+58.37%
Page of 12